These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37539927)

  • 1. SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer.
    Li J; Wang X; Li Z; Li M; Zheng X; Zheng D; Wang Y; Xi M
    Curr Cancer Drug Targets; 2024; 24(8):820-834. PubMed ID: 37539927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.
    Qi J; Li J; Zhu X; Zhao S
    PLoS One; 2024; 19(7):e0304597. PubMed ID: 38954708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R; Wang H; Yang B
    Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells.
    Yao H; Li J; Zhou D; Pan X; Chu Y; Yin J
    Int J Clin Oncol; 2024 Mar; 29(3):333-344. PubMed ID: 38172354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
    Jiang D; Ren C; Yang L; Li F; Yang X; Zheng Y; Ji X; Tian Y
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2433-2441. PubMed ID: 34028125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway.
    Li N; Wang XL; Ge R; Wang Y; Tian XL; Zhu GQ; Zhou B
    J Cell Physiol; 2024 Jun; 239(6):e31267. PubMed ID: 38558303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte differentiation factor 1 enhances cervical cancer cell viability and migration by activating the PI3K/AKT pathway.
    Chen C; Liao J; Sun X
    J Obstet Gynaecol; 2024 Dec; 44(1):2362420. PubMed ID: 38864525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer cell-derived Tie1 expression via PI3K/AKT signaling pathway promotes tumor progression.
    Wei Y; Yu P; Zhao Z; Sun C; Sun Q; Bai R; Gao W; Yang P
    Exp Cell Res; 2024 Jun; 439(1):114060. PubMed ID: 38719173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Zheng Y; Yang Y; Zhu W; Liu R; Liu A; Zhang R; Lei W; Huang S; Liu Y; Hu Q
    Braz J Med Biol Res; 2024; 57():e13796. PubMed ID: 39166606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
    Xiao W; Liu Y; Dai M; Li Y; Peng R; Yu S; Liu H
    Int J Mol Med; 2020 Aug; 46(2):700-708. PubMed ID: 32626924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRDM4 inhibits cell proliferation and tumorigenesis by inactivating the PI3K/AKT signaling pathway through targeting of PTEN in cervical carcinoma.
    Yang WT; Chen M; Xu R; Zheng PS
    Oncogene; 2021 May; 40(18):3318-3330. PubMed ID: 33846573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
    J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway.
    Ye G; Lu Q; Zhao W; Du D; Jin L; Liu Y
    Tumour Biol; 2014 Nov; 35(11):11261-7. PubMed ID: 25113250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway.
    Wang J; Yang K; Yang X; Jin T; Tian Y; Dai C; Xu F
    Mol Carcinog; 2024 Jul; 63(7):1275-1287. PubMed ID: 38578157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.